Keyword: changes in Vivus management board
News
22.07.2013
- Vivus has agreed to give dissident shareholder First Manhattan a board majority, ending an acrimonious proxy fight and bringing in a new CEO to the drugmaker accused of bungling...
News
11.07.2013
- QVT Financial, the third-largest shareholder in obesity drugmaker Vivus, intends to vote for the full slate of nine directors proposed by dissident investor First Manhattan, a...
